41-dependent adhesion strengthening under mechanic
http://www.100md.com
细胞生物学杂志 2005年第12期
1 Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel
2 Department of Medicine, University of California, San Diego, La Jolla, CA 9209
3 Center for Nano Science, Ludwigs-Maximilians-Universitt, Munich D-80799, Germany
4 Department of Pathology, Vascular Biology Program, Children's Hospital
5 Department of Surgery, Vascular Biology Program, Children's Hospital
6 Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115
The capacity of integrins to mediate adhesiveness is modulated by their cytoplasmic associations. In this study, we describe a novel mechanism by which 4-integrin adhesiveness is regulated by the cytoskeletal adaptor paxillin. A mutation of the 4 tail that disrupts paxillin binding, 4(Y991A), reduced talin association to the 41 heterodimer, impaired integrin anchorage to the cytoskeleton, and suppressed 41-dependent capture and adhesion strengthening of Jurkat T cells to VCAM-1 under shear stress. The mutant retained intrinsic avidity to soluble or bead-immobilized VCAM-1, supported normal cell spreading at short-lived contacts, had normal 4-microvillar distribution, and responded to inside-out signals. This is the first demonstration that cytoskeletal anchorage of an integrin enhances the mechanical stability of its adhesive bonds under strain and, thereby, promotes its ability to mediate leukocyte adhesion under physiological shear stress conditions.
D.R. Overby's present address is Department of Biomedical Engineering, Tulane University, New Orleans, LA 70118.
Abbreviations used in this paper: AFM, atomic force microscopy; HUVEC, human umbilical vein endothelial cell; siRNA, short inhibitory RNA; wt, wild type.
Introduction
Circulating leukocytes rapidly develop firm adhesion to vessel wall ligands through their various integrin receptors 47, 41 (VLA-4), L2 (LFA-1), and M2 (Mac-1; Alon and Feigelson, 2002). Integrins bind their respective endothelial ligands under shear flow at lower efficiency than selectins (Springer, 1994). Adhesive tethers form over a fraction of a second and depend on the ability of the nascent adhesive bond to withstand disruptive shear force. In contrast to selectins, all leukocyte integrins can undergo instantaneous up-regulation of their affinity or avidity to endothelial ligands upon exposure to endothelial chemokines (Kinashi, 2005). In addition, integrins can undergo conformational changes upon ligand binding (Hynes, 2002). Cytoskeletal constraints of integrins may also control integrin adhesiveness (van Kooyk and Figdor, 2000). Previous studies on leukocyte (L)-selectin function regulation have shown that preformed cytoskeletal associations of L-selectin with the actin cytoskeleton control the ability of ligand-occupied selectin to stabilize nascent tethers under shear flow and capture leukocytes under physiological shear stresses (Kansas et al., 1993; Dwir et al., 2001). This raised the possibility that specialized subsets capable of interacting with their respective endothelial ligands under physiological shear flow may also need to properly anchor to the cytoskeleton. Although selectins and integrins are structurally distinct, we hypothesized that 4 integrin bonds forming under disruptive shear stresses may share a common regulatory mechanism with L-selectin bonds. However, as alterations in cytoskeletal constraints of integrins can modify affinity, clustering, and ligand-induced conformational rearrangements (Carman and Springer, 2003), the direct contribution of integrin anchorage to adhesive outcome has been difficult to dissect.
In this study, we unraveled novel adhesive properties of an 4-tail mutant with disrupted association with the cytoskeletal adaptor paxillin (Liu et al., 1999). We found that blocking the 4–paxillin interaction markedly impaired the integrin's ability to anchor to the cytoskeleton in Jurkat T cells. Although not essential for 41 affinity, ligand-induced conformational changes, surface clustering and topography, or redistribution at short static contacts, paxillin association with 41 was crucial for 41–VCAM-1 bonds to resist mechanical stress. These results suggest that subsecond stabilization of 4 tethers depends on the ability of ligand-occupied 4 integrins to properly anchor to the cytoskeleton. This work also highlights the key role of the subunit of 41 in postligand binding adhesion strengthening of the integrin under mechanical strain.
Results
Paxillin association with the 4-cytoplasmic domain is required for cell resistance to detachment by shear stressPaxillin binding to the 4-cytoplasmic domain is important for integrin 41 signaling but not for adhesion developed in shear-free conditions (Rose et al., 2003). To examine the role of paxillin binding in 41-mediated adhesion under shear stress, we analyzed the resistance to shear-induced detachment from the 41 ligand VCAM-1 of 4-deficient JB4 Jurkat T cells transfected with either wild-type (wt) 4 (JB4-wt) or the paxillin binding–defective 4(Y991A) mutant JB4-4(Y991A) (Rose et al., 2003). JB4-4(Y991A) cells were less resistant to shear-induced detachment than their JB4-wt counterparts (Fig. 1 A). Notably, bivalent VCAM-1 (VCAM-1–Fc) was much more potent than monovalent soluble VCAM-1 (sVCAM-1) in supporting 41-specific adhesion (Fig. 1 A), but it still could not rescue the adhesive defect of the 4(Y991A) mutant. These results were confirmed with multiple clones expressing similar levels of 4 and 1 subunits as well as the 1 activation epitope 15/7 (Fig. 1 B and not depicted). Nevertheless, resistance to detachment from different densities of either ICAM-1–Fc or ICAM-1 was comparable between wt- and mutant 41–expressing cells (Fig. 1 C). In agreement with these results, VLA-4–dependent adhesion to TNF-stimulated human umbilical vein endothelial cells (HUVECs) was reduced in Jurkat cells expressing the 4(Y991A) mutant (Fig. 1 D), in particular at shear stresses 5 dyn/cm2, within the upper range of shear stresses prevailing in postcapillary venules where the majority of lymphocyte extravasation takes place (Firrell and Lipowsky, 1989). Whereas most cells expressing the wt 4 firmly arrested on the stimulated HUVEC via their VLA-4, a significant fraction of 4(Y991A) mutant–expressing cells failed to arrest and established endothelial (E)-selectin–dependent rolling on the HUVEC (Fig. 1 D). In the absence of functional E-selectin, the shear resistance of cells expressing the 4(Y991A) mutant was much lower than the shear resistance of cells expressing wt 4 (Fig. 1 D). Because the contribution of LFA-1 to Jurkat arrest was minimal, these data suggest that the Y991A 4 mutant is deficient in establishing 41-mediated shear resistance on endothelial cells expressing VCAM-1 as well as on substrates coated with isolated VCAM-1.
Notably, preformed clustering of wt and mutant 4 subunits on JB4 cells was essentially identical (Fig. 2 A). Real time imaging of JB4 cells that adhered on VCAM-1 also showed identical cell spreading as well as the distribution of both mutant and wt 4 during 1-min cellular contacts before shear application (WT: n = 44, 16% round, 54% polarized with uniform 4, 30% polarized with patched 4; Y911A: n = 27, 18% round, 52% polarized with uniform 4, 30% polarized with patched 4; Fig. 2 B). Notably, the strength of resistance to detachment developed by wt 4 did not correlate with the degree of patching (Fig. 2 B) in contrast to reports on LFA-1–dependent systems (Constantin et al., 2000; Kim et al., 2004). Thus, a mutation of the 4 tail defective in paxillin binding prevents 41-mediated resistance to shear-induced cell detachment independent of cell spreading and 4 patching on VCAM-1.
The 4(Y991A) mutation blocks paxillin association with the 4 tail selectively (Liu et al., 1999). As an alternative test of the role of the 4–paxillin interaction, we exploited a recently identified small molecule inhibitor of this interaction. The compound, designated A7B7C7, blocks the 4–paxillin interaction and interferes with 41-dependent cell migration (Ambroise et al., 2002). This inhibitor, but not a control compound (A6B6C6), attenuated the shear resistance of wt 41–mediated Jurkat cell adhesion to VCAM-1 (Fig. 3 A, left) but had no effect on the residual shear resistance developed by the JB4-4(Y991A) cells (Fig. 3 A, right). Adhesion mediated by the L2–ICAM-1 interaction was also insensitive to the inhibitor (not depicted). Knocking down paxillin expression by up to 75% using transient short inhibitory RNA (siRNA) silencing (Fig. 3 B) resulted in reduced adhesiveness of wt 41–mediated Jurkat cell adhesion to VCAM-1 (Fig. 3 C), with no inhibition of adhesiveness mediated by the 4(Y991A) mutant (Fig. 3 C). Notably, LFA-1–dependent adhesion to ICAM-1 was also insensitive to identical paxillin silencing (not depicted). Thus, both genetic and pharmacological approaches indicate that the 4–paxillin interaction increases the resistance of 41–VCAM-1 contacts to detachment by disruptive shear stresses.
Paxillin association with the 4 subunit promotes 41 anchorage to the cytoskeletonPaxillin binds a number of actin-binding proteins such as talin and vinculin (Brown and Turner, 2004) and does so at sites distinct from the 4-binding site (Liu and Ginsberg, 2000). We next quantified the fraction of detergent-resistant wt 4 or 4(Y991A) retained on NP-40–solubilized cells using fluorescence-tagged integrin-bound 4 mAb (Fig. 4 A). Retention of intact wt and 4(Y991A) was similar and low (20% of the total surface 4; Fig. 4 A). However, the addition of anti–mouse Ig to cluster the mAb-bound wt 4 markedly increased the association of 41 surface integrin with the detergent-insoluble cytoskeleton (Fig. 4 B). In contrast, the same treatment produced a negligible increase in the cytoskeletal association of 4(Y991A)1 (Fig. 4 B). Thus, the 4(Y991A) mutant fails to anchor properly to the actin cytoskeleton in Jurkat T cells.
The 4(Y991A) mutant poorly associates with talin and does not respond to talin suppressionIn light of this poor cytoskeletal anchorage of 4(Y991A)1, we next compared the level of talin associated with the wt or mutant 41 complex in nonadherent Jurkat cells. Notably, constitutive talin binding to the 4(Y991A)1 complex was significantly reduced compared with the wt integrin, as was evident from coprecipitation analysis (Fig. 5 A). Knocking down up to 65% of the total talin content in wt 41–expressing Jurkat cells (Fig. 5 B) retained integrin expression (not depicted) but resulted in significant reduction in their 41-mediated shear resistance on both sVCAM-1 and VCAM-1–Fc (Fig. 5 C, left and right insets, respectively). Notably, identical suppression of talin expression in the 4(Y991A)1-expressing Jurkat cells (Fig. 5 B) had no effect on their low shear resistant adhesion to identical VCAM-1 substrates (Fig. 5 C, right). These results collectively suggest that paxillin association with 41 also recruits talin to the 4–paxillin complex and may enhance talin association with the 1 subunit tail. Thus, both paxillin and talin associations promote 41-dependent cell resistance to detachment from VCAM-1 under shear stress.
4-Paxillin association is not required for 41 avidity for VCAM-1 but increases 4 bond stiffnessAlthough the affinity of integrin 4(Y991A)1 to soluble VCAM-1–Fc is retained (Rose et al., 2003), we considered that Jurkat cells expressing the 4(Y991A)1 mutant might fail to develop shear resistant adhesion as a result of reduced avidity for surface-bound VCAM-1. Comparing wt 41 with 4(Y991A)1 adhesiveness to VCAM-1–coated beads in the absence of applied shear stress, we found that JB4-wt and JB4-4(Y991A) cells bound identically to magnetic beads coated with increasing site densities of VCAM-1–Fc (Fig. 6 A), which is supportive of the normal adhesion of 4(Y991A)1-expressing cells under static conditions. Nevertheless, when VCAM-1–coated beads that bound to JB4-wt cells were exposed to abrupt mechanical stress, these beads were displaced significantly less than beads prebound to JB4-4(Y991A) cells (Fig. 6 B and Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb.200503155/DC1). 4 resistance to displacement required an intact actin cytoskeleton, as JB4-wt cells pretreated with the F-actin–severing drug cytochalasin D exhibited even greater displacement in response to abrupt magnetic stress (Fig. 6 C). These findings, together with the shear-based detachment assays (Fig. 1), collectively suggest that paxillin association with the 41 heterodimer and an intact actin cytoskeleton are both required for ligand-occupied 41 to develop stress-resistant adhesive bonds.
Paxillin association with the 4 tail augments 4-mediated T cell capture on VCAM-1 and MadCAM-1 under shear flowThe 41 and 47 integrins mediate leukocyte capture under physiological shear flow (Alon et al., 1995; Berlin et al., 1995). Therefore, we compared the ability of mutant 4(Y991A) versus wt 4 to support 41-dependent T cell capture by monovalent and bivalent VCAM-1 under continuous shear flow. Consistent with its defective resistance to shear force, 4(Y991A)1 mediated reduced cell capture and arrest on a large range of densities of either monovalent (sVCAM) or bivalent (VCAM-Fc) VCAM-1 (Fig. 7, A and B). This differential behavior was also manifested at different levels of shear stress that were tested (Fig. 7 B, first two panels). Notably, whereas disruption of the actin cytoskeleton by cytochalasin D resulted in marked inhibition of both cell capture and arrest mediated by wt 41, cytochalasin D had no effect on the residual adhesions mediated by the 4(Y991A)1 mutant (Fig. 7 A). Interestingly, the duration of individual 41 tethers, which is a measure of integrin affinity to the ligand (Feigelson et al., 2001), was not altered upon the loss of paxillin binding (Fig. 7 A). Thus, for optimal cell capture under shear flow, the 4 tail of 41 requires associations with the intact actin cytoskeleton.
Jurkat cells express low levels of the 7 integrin subunit; thus, >95% of their 4-integrin subunits are found in 41 heterodimers. Nevertheless, JB4-wt cell capture on high density of the bivalent 47-integrin ligand MadCAM-1–Fc (Berlin et al., 1993) was inhibited by the anti-47 antibody Act-1 (unpublished data). The JB4-4(Y991A) cells formed fivefold fewer tethers on MadCAM-1 than JB4-wt cells, with a diminished fraction of tethers followed by immediate arrests (Fig. 7 B, right). Thus, paxillin association with the 4 subunit enhances the ability of 4 to promote adhesive tethers in the context of both 1 and 7 integrins under continuously applied disruptive shear stress.
Preferential localization of receptors to microvilli increases their availability for interactions with counter ligands under shear flow (von Andrian et al., 1995). Electron microscopic analysis of wt 4 and the 4(Y991A)-tail mutant revealed identical distribution of these variants to microvillar compartments (82 ± 4% for wt 4, n = 222; 80 ± 6% for the 4(Y991A) mutant, n = 196; Fig. 5 C). Furthermore, a higher ratio of the 4(Y991A)-tail mutant localized on microvillar tips than wt 4 (a 4.5 tip/base ratio for the mutant vs. only 1.8 tip/base ratio for wt 4). The number and size of microvillar projections in JB4-wt and JB4-4(Y991A) cells were also comparable (Fig. 7 C). Thus, the enhanced ability of wt 41 to promote adhesive tethers under shear flow was not the result of its preferential distribution to cellular microvilli or to increased localization on microvillar tips.
The 4(Y991A)1 mutant fails to generate productive adhesive bonds with VCAM-1 under disruptive forcesTo examine the effects of disrupting the 4–paxillin interaction at a single molecule level and in the presence of an external force other than shear stress, we next measured the force of unitary adhesive interactions between wt 41 or the 4(Y991A)1 mutant and immobilized VCAM-1 by atomic force microscopy (AFM). JB4-wt or JB4-(Y991A) cells were coupled to the end of an AFM cantilever (Fig. 8 A) and lowered onto a VCAM-1–Fc-coated surface. After a 0.5-s contact, the frequency of productive adhesive events and their strength were analyzed by the degree of deflection experienced by the cantilever during its retraction from the adhesive substrate. Both cell types detached from the VCAM-1 substrate through single jumps, suggesting the breakage of individual bonds during cantilever retraction (Fig. 8 B). The adhesion frequencies of all experiments were maintained below 30%, a level assumed to reflect single 41–VCAM-1 interactions (Zhang et al., 2004). The specificity of the adhesive events detected in this system were confirmed by a similar 70% reduction in total binding events by the blockade of wt 41 with Bio1211 (Lin et al., 1999) or by omission of VCAM-1 from the substrate (Fig. 8 C and not depicted). As indicated by the force histograms derived for JB4-wt or JB4-4(Y991A) cells (Fig. 8 C), the frequency of productive adhesive events developed by 4(Y991A)1 was up to 10-fold lower than those developed by 41 after background subtraction. The distribution of unbinding (rupture) forces measured for the two integrin variants was, however, similar (Fig. 8 C). Thus, paxillin association with the 4 subunit dramatically augments the ability of 41 to form adhesive tethers that resist disruptive forces irrespective to whether these forces are applied during a vertical force loading (AFM) or during cell rotation (shear stress).
Paxillin association with 4 augments shear resistance of integrin tethers independent of ligand-induced conformational changesThe aforementioned data suggest that paxillin binding to 4 is required for mechanical stabilization of cell attachments rather than for cytoplasmic induction of high affinity integrin conformations. Ligand binding to integrins can induce conformational changes in the integrin, resulting in high affinity conformations (Du et al., 1991; Shimaoka et al., 2002). Therefore, we considered the possibility that the reduced tether formation by the 4(Y991A) mutant could reflect defective, instantaneous ligand-induced conformational changes in the integrin under shear stress. We first verified that the 41 ligand Bio1211 provoked similar conformational changes in 41 and 4(Y991A)1 under shear-free conditions, as indicated by the identical induction of the 1 ligand–induced binding site reporter 15/7 epitope by increasing doses of the monovalent 41-specific ligand Bio1211 (Fig. 9 A; Lin et al., 1999). We next tested the intrinsic attachment efficacy of either wt 4 or the 4Y991A mutant to surface-immobilized 4 mAb in the absence of ligand occupancy of the integrin. Notably, the HP1/2 mAb binding to 4 integrins is not sensitive to their affinity to or rearrangement by native ligands (Feigelson et al., 2001) and, thus, should be insensitive to intrinsic or ligand-induced affinity changes under shear stress. Notably, in the presence of shear flow, the 4(Y991A) mutant formed adhesive tethers to immobilized HP1/2 mAb much less efficiently than wt 4 (Fig. 9 B), as was observed for VCAM-1 (Fig. 1). In addition, adhesive contacts generated by the 4(Y991A) mutant after 1 min of static contact also exhibited poor resistance to detachment by increasing shear forces relative to wt 4–mediated contacts (Fig. 9 C). Thus, paxillin association with the 4-integrin tail enhances the ability of the integrin subunit to generate resistance to detachment forces independently of ligand-induced conformational rearrangements under shear stress conditions.
The 4(Y991A)1 mutant responds to inside-out stimulation but develops weaker adhesions to VCAM-1 under shear flowCellular stimulation by various agonists increases integrin adhesiveness in various contexts (Hynes, 2002). We next examined the effects of two prototypic agonists, PMA, a direct agonist of diacyl glycerol–dependent PKCs, and the chemokine SDF-1 (CXCL12) on mutant and wt 4. Exposure of JB4-4(Y991A) cells to soluble PMA or to immobilized SDF-1 resulted in enhanced resistance to detachment from VCAM-1–bearing surfaces (Fig. 10 A), although the overall adhesion strength developed by the 4(Y991A) mutant was lower than that developed by the intact integrin. Further analysis of adhesive tethers formed on VCAM-1 at subsecond contacts also indicated that the ability of initial 4(Y991A)1-dependent Jurkat tethers to convert to immediate firm arrests was enhanced by PMA (Fig. 10 B). Likewise, JB4-4(Y991A) cells efficiently responded to in situ subsecond signals from SDF-1 with a twofold elevated frequency of 41-dependent tethers on VCAM-1 (Fig. 10 B, right). However, overall SDF-1–stimulated tethers mediated by 4(Y991A) cells remained lower than wt 4–mediated tethers. Thus, although the mutant 4 underwent robust activation in response to both chemokine and PMA inside-out signals, its impaired cytoskeletal associations resulted in overall reduced adhesion to VCAM-1 under shear stress.
Discussion
This study shows that the disruption of paxillin binding to the integrin 4 tail abrogates its anchorage to the actin cytoskeleton and impairs the ability of integrin ligand bonds to withstand immediate rupture by shear stress, an AFM-pulling device, or abruptly applied magnetic force. Despite normal distribution on the cell surface and retained avidity to immobilized VCAM-1, in the presence of applied forces, this anchorage-deficient mutant poorly mediates tether formation and rapid adhesion strengthening on its ligand. Paxillin-dependent cytoskeletal anchoring of ligand-occupied 4 integrins may thus underlie their unique capacity to resist disruptive forces and support leukocyte adhesion under shear flow. Thus, although cytoskeletal constraints of integrins were predicted to restrict mobility and clustering on the cell surface and reduce cell adhesiveness (Kucik et al., 1996; Yauch et al., 1997; Kim et al., 2004), we propose that 4 integrins must retain correct cytoskeletal associations to resist immediate rupture by shear stresses exerted at leukocyte contacts with target blood vessels. Our findings indicate that 4-integrin anchorage to the cell cytoskeleton is critical for nascent adhesive contacts to resist immediate rupture by shear stress, but it is not required for integrin binding to the ligand nor for ligand-induced conformational rearrangements in the absence of external force. The anchorage deficiency of the 4-tail mutant resulted in an inability to develop adhesion to a high affinity mAb, which binds the integrin independently of affinity to native ligands (Feigelson et al., 2001; Kinashi et al., 2004). Altogether, these data suggest that paxillin associations with the 4 tail control (a postligand occupancy anchorage step that is critical for tether stabilization under stress), which is a mechanical property underlying the ability of lymphocytes to capture and arrest on endothelial 4-integrin ligands under shear flow. Our experiments on cytokine-activated endothelial cells also predict an increased contribution of this 4–paxillin association to T cells interacting with endothelial beds expressing 4-integrin ligands in the absence of endothelial selectins.
Integrin affinity is controlled by -subunit associations with the talin head domain (Tadokoro et al., 2003) and by Rap1 (Kinashi, 2005) via effectors such as RAPL (regulator of adhesion and cell polarization enriched in lymphoid tissues; Katagiri et al., 2004). The effect of RAPL requires -tail sequences (Katagiri et al., 2004) that are distant from the paxillin-binding site on 4 (Liu and Ginsberg, 2000). The retained affinity of the 4(Y991A) mutant and its capacity to mediate static adhesion suggest that lack of paxillin association with the 4-integrin tail does not interfere with Rap1-dependent signals whether mediated through RAPL or other Rap1 effectors. The reduction in talin association with 4(Y991A)1 did not alter basal 41 affinity for VCAM-1 (Rose et al., 2003), suggesting that the paxillin-mediated association of talin with 41 does not contribute to affinity modulation. On the other hand, the extent of these cytoskeletal associations and an intact actin cytoskeleton critically determine the mechanical strength of 41 VCAM-1 bonds (i.e., tether formation, adhesion strengthening, and resistance to mechanical stress). Thus, we propose that the ability of 4 integrins to translate ligand occupancy into immediate mechanical stability of subsecond adhesive contacts requires paxillin and talin-mediated linkages of 41 to the actin cytoskeleton. The regulation of 41 adhesiveness by talin has never been addressed, especially not under shear stress conditions. The finding that talin suppression impairs the strengthening of wt 41 bonds under strain is reminiscent of results reporting the involvement of talin1 in ligand-driven 51-cytoskeletal bonds in fibroblasts (Jiang et al., 2003). Although different integrins may anchor differently to the cytoskeleton in distinct cell types, this involvement of talin in both 4- and 5-integrin associations with the actin cytoskeleton is consistent with the notion that talin, apart from its role in integrin affinity regulation (Tadokoro et al., 2003), is a key postligand occupancy adaptor that promotes integrin bond stabilization in distinct mechanical contexts and cellular environments.
Our results highlight the role of the -integrin subunit rather than the subunit in postligand binding adhesion strengthening of the 41–VCAM-1 bond under mechanical strain. Previous findings suggested that a nearly complete truncation of the 4-cytoplasmic tail impairs 41 adhesion strengthening without altering initial cell capture to VCAM-1 under shear flow (Alon et al., 1995; Kassner et al., 1995). This truncation of the 4-integrin tail also reduced integrin mobility (Yauch et al., 1997) and may have increased integrin cytoskeletal anchorage via the intact 1 subunit, although this was not experimentally demonstrated. Therefore, in these earlier studies, it was impossible to distinguish between the contributions of 4 anchorage versus mobility to rapid mechanical stabilization of 4 integrin–mediated tethers. Our present results provide the first direct evidence for a positive role of 4 anchorage for the earliest stabilization events of 41–VCAM-1 bonds subjected to mechanical strain.
In addition to the 4 Y991 residue, the phosphorylation level of the 4 serine 988 has been shown to control the degree of 4 association with paxillin (Han et al., 2001). A dephosphorylated serine variant mimicked by the phosphodeficient mutant 4 S988A was reported to bind paxillin at enhanced levels (Nishiya et al., 2005). Interestingly, this phosphodeficient mutant did not properly anchor to the cytoskeleton and supported reduced adhesiveness to VCAM-1 (unpublished data). These findings, together with the paxillin-silencing data of this study, suggest that paxillin binding to the 4 subunit is required but is insufficient to anchor 4 to the cytoskeleton. Thus, 4 phosphorylation, which is postulated to attenuate paxillin binding to the 4 subunit, is in fact required, at least at a basal level, for proper cytoskeletal 4 association and productive adhesiveness under shear stress. Overphosphorylation of 4, which reduces paxillin association, may, on the other hand, attenuate both anchorage and adhesiveness. Studies are ongoing to address both the positive and negative effects of serine phosphorylation on 4 anchorage and function under strain.
4 association with paxillin enhances the activation of the focal adhesion kinases FAK and PYK-2 after 41 ligation (Liu et al., 1999; Rose et al., 2003). This association also restricts Rac activation at the leading edge via recruitment of the Arf GTPase-activating protein (Nishiya et al., 2005). Nevertheless, at 1-min contacts with VCAM-1, cells expressing the 4-tail mutant spread normally on VCAM-1. Suppression of tyrosine phosphorylation or inhibition of PYK-2 activity in Jurkat T cells had no effect on 41-mediated adhesion strengthening developed under shear stress (unpublished data). Thus, the ability of paxillin association with 41 to enhance integrin anchorage to the cytoskeleton and promote mechanical stability of adhesive tethers at short-lived contacts is distinct from its roles in focal adhesion turnover and Rac deactivation during cell spreading on VCAM-1–containing substrates (Nishiya et al., 2005). Altogether, our findings suggest that modulating mechanical properties of 4 integrins by the inhibition of specific associations between 4-cytoplasmic tails and the cytoskeleton may be a selective strategy to fine tune integrin-mediated adhesion under shear stress without altering integrin affinity.
Materials and methods
Reagents and antibodiesRecombinant seven-domain human VCAM-1 (sVCAM-1) was provided by B. Pepinsky (Biogen, Cambridge, MA). VCAM-1–Fc fusion protein containing seven-domain VCAM-1 fused to IgG was generated as described previously (Rose et al., 2000). VCAM-1–Fc constructed from domains 1 and 2 of VCAM-1 fused to Fc, termed 2D VCAM-1–Fc, was provided by B. Pepinsky. Affinity-purified human full-length spleen-derived ICAM-1 was a gift from T. Springer (Harvard University, Boston, MA). ICAM-Fc and SDF-1 were purchased from R&D Systems. BSA (fraction V), poly-L-lysine, and Ca2+/Mg2+-free HBSS were obtained from Sigma-Aldrich. Human serum albumin (fraction V) and PMA were purchased from Calbiochem. The 4-integrin function–blocking HP1/2 mAb, the E-selectin–blocking mAb BB11, the 1-specific TS2/16 mAb, the 4-specific nonblocking 5BG10 mAb (all provided by B. Pepinsky), the 1-integrin subunit mAb 15/7 (provided by T. Yednock, Elan Pharmaceuticals, San Francisco, CA; Yednock et al., 1995), and the anti-47 Act-1 (a gift from M.J. Briskin, Millennium Pharmaceuticals, Cambridge, MA) were all used as purified Ig. Antitalin mAb (clone 8d4) was purchased from Sigma-Aldrich. Antipaxillin mAb (clone 349) was purchased from BD Transduction Laboratories. Goat polyclonal anti-4 Ab (clone C-20) was purchased from Santa Cruz Biotechnology, Inc.
Cell culture and flow cytometryJurkat cells deficient in 4 (JB4) were stably transfected with either wt 4 or 4(Y991A) cDNA as described previously (Liu et al., 1999). Cells were subcloned, and multiple clones expressing identical levels of 4 and 1 subunits were taken for functional analysis. Clones were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 mM nonessential amino acids, and antibiotics (Biological Industries). Primary HUVECs were established as previously described (Shamri et al., 2005). HUVECs were left intact or stimulated for 4 h with 0.1 ng/ml TNF- (R&D Systems) before experiments. Staining and FACS analysis were performed as previously described (Feigelson et al., 2003).
Immunofluorescence staining and immunoelectron microscopyFor 4-integrin immunostaining, Jurkat cells were washed in PBS and incubated with 10 μg/ml anti-4 B5G10 mAb for 30 min at 4°C. Cells were washed once with PBS + 5 mM EDTA and twice with PBS/0.1% BSA, and 4 integrins were stained with AlexaFluor546-conjugated anti–mouse Ab (Invitrogen) and fixed in 3% PFA in PBS (30 min at RT). Control cells were fixed before mAb incubation steps. Cells were attached to poly-L-lysine–coated glass slides, and coverslips were mounted with elvanol overnight and analyzed with a confocal microscope (TE300; Nikon) and a laser-scanning system (model 2000; Bio-Rad Laboratories).
4 localization was assessed by immunoelectron microscopy as previously described (Chen et al., 1999). In brief, cultured Jurkat cells were washed and prefixed in 0.1 M phosphate buffer, pH 7.4, containing 2% PFA and 0.05% glutaraldehyde. Washed cells in H/H medium (HBSS containing 2 mg/ml BSA and 10 mM Hepes, pH 7.4, supplemented with 1 mM CaCl2 and 1 mM MgCl2) were incubated with 10 μg/ml anti-4 B5G10 mAb for 40 min at 22°C. Washed cells were stained with 10 μg/ml rabbit anti–mouse Ig, washed, and incubated for 45 min with 5 nm gold particle–conjugated goat anti–rabbit (Aurion). Ultrathin sections (70–90 nm) of 40–60 cells for each experimental group were examined with an electron microscope (Tecnai 12; FEI) under 120 kV, and images were taken using a CCD camera (Megaview 3; Soft Imaging System). In each experimental group analyzed, the number of 4-specific gold particles on microvillar projections was compared with that on adjacent cell body compartments of identical dimensions.
siRNA-mediated silencing of paxillin and talinSilencing of talin expression in Jurkat cells was achieved by a talin1-specific 21-nucleotide siRNA (Dharmacon) corresponding to positions 6,043–6,063 relative to the talin1 mRNA start codon (Shamri et al., 2005). Silencing of paxillin was conducted as described previously (Nishiya et al., 2005). Control transfections were performed with a fluorescein-labeled 21-nucleotide duplex directed to Luciferase GL2. Transfection of T cells was performed by electroporation using the Nucleofection system (Amaxa). Transfected cells were maintained in culture medium. Talin and paxillin expression monitored by immunoblotting was maximally suppressed 72 h posttransfection, and time points were chosen for subsequent functional assays. Immunoprecipitation of 4 was performed as previously described (Feigelson et al., 2003).
Quantification of integrin anchorage to the cytoskeletonCells were stained with 10 μg/ml of the FITC-conjugated anti-4 mAb HP1/2 at 4°C for 30 min, washed twice with H/H medium supplemented with 1 mM CaCl2 and 1 mM MgCl2, and left either untreated or cross-linked with secondary antibodies at 4°C for 30 min followed by two washes as described previously (Geppert and Lipsky, 1991; Evans et al., 1999). All cells were then incubated at RT for 30 min with the cytoskeletal stabilizing buffer (CSB; 50 mM NaCl, 2 mM MgCl2, 0.22 mM EGTA, 13 mM Tris, pH 8.0, 1 mM PMSF, 10 mM iodacetamide, and 2% FCS) alone or supplemented with 0.1% NP-40. The intact cells or their recovered detergent-insoluble cytoskeletal fractions were washed in detergent-free CSB, fixed in 1% PFA/PBS, and analyzed by flow cytometry. Under these conditions, the majority of detergent-treated cells retain their shape and size. The ratio of mean fluorescence intensity recovered in detergent-treated cells divided by that of cells not exposed to the detergent yields the fraction of mAb-bound 4 integrin that is resistant to detergent extraction; i.e., anchored to the (detergent resistant) cytoskeletal fraction of the cell.
VCAM-1 microbead–binding assays and integrin bond stiffnessProtein A–coated magnetic M-280 Dynabeads (Dynal) were coated at RT with various concentrations (0.004–1 μg/ml) of 2D VCAM-Fc in H/H binding medium, washed according to the manufacturer's instructions, and stored on ice. Cells and VCAM-1–coated beads were mixed at RT for 1 min in binding medium at a concentration of 107 cells/ml at a cell/bead ratio of 1:8 followed by a threefold dilution in binding medium. The cellular side scatter, distinguishing between bead-bound and bead-free cells, was analyzed immediately in a FACScan flow cytometer (Becton Dickinson). Background binding determined with protein A–coated beads was <10% of the maximal binding observed at VCAM-1 saturation and was subtracted from the total binding results.
The mechanical stiffness of 41/VCAM-1 adhesions was measured by electromagnetic pulling cytometry using VCAM-1–coated beads (Matthews et al., 2004). The detailed method is described in supplemental material (available at http://www.jcb.org/cgi/content/full/jcb.200503155/DC1).
AFM measurementsAll force measurements were conducted at 35 ± 2°C using a previously described AFM apparatus (Benoit et al., 2000). In brief, a microfabricated Si3N4 cantilever tip (Park Scientific Instruments) was coated with 0.1 mg/ml of the anti-CD43 mAb (R&D Systems). The spring constants of the cantilevers used were determined at 4.7 ± 0.6 mN/m. A single cell was immobilized on the cantilever tip shortly before experimentation. The device was mounted with a piezo-actuator (Piezosystem Jena) on an inverted optical microscope (Carl Zeiss MicroImaging, Inc.) containing a heating stage. A diode laser beam focused on the sensor was used to measure the displacement of the cantilever by the laser beam deflection on a two-segment photodetector. The cell adhering to the cantilever was positioned above an adhesive substrate coated with 2D VCAM-1–Fc captured via human IgG Fc mAb (Jackson ImmunoResearch Laboratories). The cantilever was lowered until the sensor detected a contact force equal to a preselected value (typically 50 pN). After the contact was established for a dwelling time of 500 ms, the cell-bearing cantilever was lifted up by the piezo-actuator, and the de-adhesion force was monitored by a force–distance plot (Fig. 5 B). From this plot, the last detectable de-adhesion force was calculated. For each cell, 50–200 force–distance plots were collected within 30 min. All de-adhesion events collected in at least 10 independent experiments were presented in histograms (Fig. 5 C).
Laminar flow adhesion assaysPurified ligands or mAbs were coated on polystyrene plates as previously described (Grabovsky et al., 2000). Site densities of coated sVCAM-1 and VCAM-1–Fc were determined as previously described (Grabovsky et al., 2000; Sigal et al., 2000). The polystyrene plates were each assembled on the lower wall of the flow chamber (260-um gap) as previously described (Dwir et al., 2000; Feigelson et al., 2001). Cells were washed with cation-free H/H medium, resuspended in binding medium (H/H medium supplemented with 1 mM CaCl2 and 1 mM MgCl2), and perfused through the flow chamber at the desired shear stress. To disrupt actin cytoskeleton, cells were pretreated for 15 min with 20 μM cytochalasin D (Calbiochem) or carrier solution (0.1% DMSO). All flow experiments were conducted at 37°C. Tethers were defined as transient if cells attached briefly (<2 s) to the substrate and as arrests if they immediately arrested and remained stationary for at least 5 s of continuous flow. Frequencies of adhesive categories within differently pretreated cells or rates of cell accumulation on adhesive substrates were determined as a percentage of cells flowing immediately over the substrates, as previously described (Grabovsky et al., 2000). To assess rapid development of integrin avidity to the ligand at 1-min stationary contacts, cells were allowed to settle onto the substrate for 1 min at stasis. Flow was then initiated and increased step-wise every 5 s by a programmed set of rates. At the indicated shear stresses, the number of cells that remained bound was expressed relative to the number of cells originally settled on the substrate. Over 95% of tethers to VCAM-1 were blocked by pretreating cells with 10 μg/ml of the 4-blocking mAb HP1/2. Live imaging of 4 on Jurkat cells prelabeled with AlexaFluor488-conjugated B5G10 mAb that settled on VCAM-1 was conducted with Delta Vision Spectris RT (Applied Precision). 4 patching was quantified using Image J software (National Institutes of Health).
Online supplemental materialFig. S1 shows the analysis of VCAM-1–coated bead displacement during a magnetic force pulse applied on wt Jurkat cells. The supplemental Materials and methods section describes the experimental setup.
Acknowledgments
We thank S. Schwarzbaum for editorial assistance.
R. Alon is the Incumbent of The Tauro Career Development Chair in Biomedical Research. This research was supported by the Fogarty International Research Collaboration Awards and was partially supported by the Israel Science Foundation and MAIN, the EU6 Program for Migration and Inflammation. This work was also supported by National Institutes of Health (NIH) grants AR27214 and HL57009 to M.H. Ginsberg, NIH grant CA45548 to D.E. Ingber, and NIH grant P30AR47360 to D.M. Rose. The work of D.M. Rose was additionally supported by the Department of Veterans Affairs Merit Review Entry Program Award and by the Arthritis Foundation.
References
Alon, R., and S. Feigelson. 2002. From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin. Immunol. 14:93–104.
Alon, R., P.D. Kassner, M.W. Carr, E.B. Finger, M.E. Hemler, and T.A. Springer. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243–1253.
Ambroise, Y., B. Yaspan, M.H. Ginsberg, and D.L. Boger. 2002. Inhibitors of cell migration that inhibit intracellular paxillin/alpha4 binding: a well-documented use of positional scanning libraries. Chem. Biol. 9:1219–1226.
Benoit, M., D. Gabriel, G. Gerisch, and H.E. Gaub. 2000. Discrete interactions in cell adhesion measured by single-molecule force spectroscopy. Nat. Cell Biol. 2:313–317.
Berlin, C., E.L. Berg, M.J. Briskin, D.P. Andrew, P.J. Kilshaw, B. Holzmann, I.L. Weissman, A. Hamann, and E.C. Butcher. 1993. 47 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 74:185–195.
Berlin, C., R.F. Bargatze, J.J. Campbell, U.H. von Andrian, M.C. Szabo, S.R. Hasslen, R.D. Nelson, E.L. Berg, S.L. Erlandsen, and E.C. Butcher. 1995. 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80:413–422.
Brown, M.C., and C.E. Turner. 2004. Paxillin: adapting to change. Physiol. Rev. 84:1315–1339.
Carman, C.V., and T.A. Springer. 2003. Integrin avidity regulation: are changes in affinity and conformation underemphasized Curr. Opin. Cell Biol. 15:547–556.
Chen, C., J.L. Mobley, O. Dwir, F. Shimron, V. Grabovsky, R.L. Lobb, Y. Shimizu, and R. Alon. 1999. High affinity VLA-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow. J. Immunol. 162:1084–1095.
Constantin, G., M. Majeed, C. Giagulli, L. Piccio, J.Y. Kim, E.C. Butcher, and C. Laudanna. 2000. Chemokines trigger immediate 2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity. 13:759–769.
Du, X.P., E.F. Plow, A.L. Frelinger 3rd, T.E. O'Toole, J.C. Loftus, and M.H. Ginsberg. 1991. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell. 65:409–416.
Dwir, O., G.S. Kansas, and R. Alon. 2000. An activated L-selectin mutant with conserved equilibrium binding properties but enhanced ligand recognition under shear flow. J. Biol. Chem. 275:18682–18691.
Dwir, O., G.S. Kansas, and R. Alon. 2001. The cytoplasmic tail of L-selectin regulates leukocyte capture and rolling by controlling the mechanical stability of selectin:ligand tethers. J. Cell Biol. 155:145–156.
Evans, S.S., D.M. Schleider, L.A. Bowman, M.L. Francis, G.S. Kansas, and J.D. Black. 1999. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J. Immunol. 162:3615–3624.
Feigelson, S.W., V. Grabovsky, E. Winter, L.L. Chen, R.B. Pepinsky, T. Yednock, D. Yablonski, R. Lobb, and R. Alon. 2001. The src kinase p56Lck upregulates VLA-4 integrin affinity: implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin. J. Biol. Chem. 276:13891–13901.
Feigelson, S.W., V. Grabovsky, R. Shamri, S. Levy, and R. Alon. 2003. The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to VCAM-1 under shear flow. J. Biol. Chem. 278:51203–51212.
Firrell, J.C., and H.H. Lipowsky. 1989. Leukocyte margination and deformation in mesenteric venules of rat. Am. J. Physiol. 256:H1667–H1674.
Geppert, T.D., and P.E. Lipsky. 1991. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J. Immunol. 146:3298–3305.
Grabovsky, V., S. Feigelson, C. Chen, R. Bleijs, A. Peled, G. Cinamon, F. Baleux, F. Arenzana-Seisdedos, T. Lapidot, Y. van Kooyk, et al. 2000. Subsecond induction of 4 integrin clustering by immobilized chemokines enhances leukocyte capture and rolling under flow prior to firm adhesion to endothelium. J. Exp. Med. 192:495–505.
Han, J., S. Liu, D.M. Rose, D.D. Schlaepfer, H. McDonald, and M.H. Ginsberg. 2001. Phosphorylation of the integrin alpha 4 cytoplasmic domain regulates paxillin binding. J. Biol. Chem. 276:40903–40909.
Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673–687.
Jiang, G., G. Giannone, D.R. Critchley, E. Fukumoto, and M.P. Sheetz. 2003. Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin. Nature. 424:334–337.
Kansas, G.S., K. Ley, J.M. Munro, and T.F. Tedder. 1993. Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin. J. Exp. Med. 177:833–838.
Kassner, P.D., R. Alon, T.A. Springer, and M.E. Hemler. 1995. Specialized functional properties of the integrin 4 cytoplasmic domain. Mol. Biol. Cell. 6:661–674.
Katagiri, K., N. Ohnishi, K. Kabashima, T. Iyoda, N. Takeda, Y. Shinkai, K. Inaba, and T. Kinashi. 2004. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat. Immunol. 5:1045–1051.
Kim, M., C.V. Carman, W. Yang, A. Salas, and T.A. Springer. 2004. The primacy of affinity over clustering in regulation of adhesiveness of the integrin L2. J. Cell Biol. 167:1241–1253.
Kinashi, T. 2005. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol. 5:546–559.
Kinashi, T., M. Aker, M. Sokolovsky-Eisenberg, V. Grabovsky, C. Tanaka, R. Shamri, S. Feigelson, A. Etzioni, and R. Alon. 2004. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood. 103:1033–1036.
Kucik, D.F., M.L. Dustin, J.M. Miller, and E.J. Brown. 1996. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J. Clin. Invest. 97:2139–2144.
Lin, K., H.S. Ateeq, S.H. Hsiung, L.T. Chong, C.N. Zimmerman, A. Castro, W.C. Lee, C.E. Hammond, S. Kalkunte, L.L. Chen, et al. 1999. Selective, tight-binding inhibitors of integrin 41 that inhibit allergic airway responses. J. Med. Chem. 42:920–934.
Liu, S., and M.H. Ginsberg. 2000. Paxillin binding to a conserved sequence motif in the 4 integrin cytoplasmic domain. J. Biol. Chem. 275:22736–22742.
Liu, S., S.M. Thomas, D.G. Woodside, D.M. Rose, W.B. Kiosses, M. Pfaff, and M.H. Ginsberg. 1999. Binding of paxillin to 4 integrins modifies integrin-dependent biological responses. Nature. 402:676–681.
Matthews, B.D., D.R. Overby, F.J. Alenghat, J. Karavitis, Y. Numaguchi, P.G. Allen, and D.E. Ingber. 2004. Mechanical properties of individual focal adhesions probed with a magnetic microneedle. Biochem. Biophys. Res. Commun. 313:758–764.
Nishiya, N., W.B. Kiosses, J. Han, and M.H. Ginsberg. 2005. An 4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat. Cell Biol. 7:343–352.
Rose, D.M., P.M. Cardarelli, R.R. Cobb, and M.H. Ginsberg. 2000. Soluble VCAM-1 binding to 4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells. Blood. 95:602–609.
Rose, D.M., S. Liu, D.G. Woodside, J. Han, D.D. Schlaepfer, and M.H. Ginsberg. 2003. Paxillin binding to the 4 integrin subunit stimulates LFA-1 (integrin L2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2. J. Immunol. 170:5912–5918.
Shamri, R., V. Grabovsky, J.M. Gauguet, S. Feigelson, E. Manevich, W. Kolanus, M.K. Robinson, D.E. Staunton, U.H. von Andrian, and R. Alon. 2005. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat. Immunol. 6:497–506.
Shimaoka, M., J. Takagi, and T.A. Springer. 2002. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31:485–516.
Sigal, A., D.A. Bleijs, V. Grabovsky, S.J. van Vliet, O. Dwir, C.G. Figdor, Y. van Kooyk, and R. Alon. 2000. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J. Immunol. 165:442–452.
Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301–314.
Tadokoro, S., S.J. Shattil, K. Eto, V. Tai, R.C. Liddington, J.M. de Pereda, M.H. Ginsberg, and D.A. Calderwood. 2003. Talin binding to integrin beta tails: a final common step in integrin activation. Science. 302:103–106.
van Kooyk, Y., and C.G. Figdor. 2000. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr. Opin. Cell Biol. 12:542–547.
von Andrian, U.H., S.R. Hasslen, R.D. Nelson, S.L. Erlandsen, and E.C. Butcher. 1995. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell. 82:989–999.
Yauch, R.L., D.P. Felsenfeld, S.K. Kraeft, L.B. Chen, M.P. Sheetz, and M.E. Hemler. 1997. Mutational evidence for control of cell adhesion through integrin recruitment, independent of ligand binding. J. Exp. Med. 186:1347–1355.
Yednock, T.A., C. Cannon, C. Vandevert, E.G. Goldbach, G. Shaw, D.K. Ellis, C. Liaw, L.C. Fritz, and L.I. Tanner. 1995. 41 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J. Biol. Chem. 270:28740–28750.
Zhang, X., S.E. Craig, H. Kirby, M.J. Humphries, and V.T. Moy. 2004. Molecular basis for the dynamic strength of the integrin 41/VCAM-1 interaction. Biophys. J. 87:3470–3478.(Ronen Alon, Sara W. Feige)
2 Department of Medicine, University of California, San Diego, La Jolla, CA 9209
3 Center for Nano Science, Ludwigs-Maximilians-Universitt, Munich D-80799, Germany
4 Department of Pathology, Vascular Biology Program, Children's Hospital
5 Department of Surgery, Vascular Biology Program, Children's Hospital
6 Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115
The capacity of integrins to mediate adhesiveness is modulated by their cytoplasmic associations. In this study, we describe a novel mechanism by which 4-integrin adhesiveness is regulated by the cytoskeletal adaptor paxillin. A mutation of the 4 tail that disrupts paxillin binding, 4(Y991A), reduced talin association to the 41 heterodimer, impaired integrin anchorage to the cytoskeleton, and suppressed 41-dependent capture and adhesion strengthening of Jurkat T cells to VCAM-1 under shear stress. The mutant retained intrinsic avidity to soluble or bead-immobilized VCAM-1, supported normal cell spreading at short-lived contacts, had normal 4-microvillar distribution, and responded to inside-out signals. This is the first demonstration that cytoskeletal anchorage of an integrin enhances the mechanical stability of its adhesive bonds under strain and, thereby, promotes its ability to mediate leukocyte adhesion under physiological shear stress conditions.
D.R. Overby's present address is Department of Biomedical Engineering, Tulane University, New Orleans, LA 70118.
Abbreviations used in this paper: AFM, atomic force microscopy; HUVEC, human umbilical vein endothelial cell; siRNA, short inhibitory RNA; wt, wild type.
Introduction
Circulating leukocytes rapidly develop firm adhesion to vessel wall ligands through their various integrin receptors 47, 41 (VLA-4), L2 (LFA-1), and M2 (Mac-1; Alon and Feigelson, 2002). Integrins bind their respective endothelial ligands under shear flow at lower efficiency than selectins (Springer, 1994). Adhesive tethers form over a fraction of a second and depend on the ability of the nascent adhesive bond to withstand disruptive shear force. In contrast to selectins, all leukocyte integrins can undergo instantaneous up-regulation of their affinity or avidity to endothelial ligands upon exposure to endothelial chemokines (Kinashi, 2005). In addition, integrins can undergo conformational changes upon ligand binding (Hynes, 2002). Cytoskeletal constraints of integrins may also control integrin adhesiveness (van Kooyk and Figdor, 2000). Previous studies on leukocyte (L)-selectin function regulation have shown that preformed cytoskeletal associations of L-selectin with the actin cytoskeleton control the ability of ligand-occupied selectin to stabilize nascent tethers under shear flow and capture leukocytes under physiological shear stresses (Kansas et al., 1993; Dwir et al., 2001). This raised the possibility that specialized subsets capable of interacting with their respective endothelial ligands under physiological shear flow may also need to properly anchor to the cytoskeleton. Although selectins and integrins are structurally distinct, we hypothesized that 4 integrin bonds forming under disruptive shear stresses may share a common regulatory mechanism with L-selectin bonds. However, as alterations in cytoskeletal constraints of integrins can modify affinity, clustering, and ligand-induced conformational rearrangements (Carman and Springer, 2003), the direct contribution of integrin anchorage to adhesive outcome has been difficult to dissect.
In this study, we unraveled novel adhesive properties of an 4-tail mutant with disrupted association with the cytoskeletal adaptor paxillin (Liu et al., 1999). We found that blocking the 4–paxillin interaction markedly impaired the integrin's ability to anchor to the cytoskeleton in Jurkat T cells. Although not essential for 41 affinity, ligand-induced conformational changes, surface clustering and topography, or redistribution at short static contacts, paxillin association with 41 was crucial for 41–VCAM-1 bonds to resist mechanical stress. These results suggest that subsecond stabilization of 4 tethers depends on the ability of ligand-occupied 4 integrins to properly anchor to the cytoskeleton. This work also highlights the key role of the subunit of 41 in postligand binding adhesion strengthening of the integrin under mechanical strain.
Results
Paxillin association with the 4-cytoplasmic domain is required for cell resistance to detachment by shear stressPaxillin binding to the 4-cytoplasmic domain is important for integrin 41 signaling but not for adhesion developed in shear-free conditions (Rose et al., 2003). To examine the role of paxillin binding in 41-mediated adhesion under shear stress, we analyzed the resistance to shear-induced detachment from the 41 ligand VCAM-1 of 4-deficient JB4 Jurkat T cells transfected with either wild-type (wt) 4 (JB4-wt) or the paxillin binding–defective 4(Y991A) mutant JB4-4(Y991A) (Rose et al., 2003). JB4-4(Y991A) cells were less resistant to shear-induced detachment than their JB4-wt counterparts (Fig. 1 A). Notably, bivalent VCAM-1 (VCAM-1–Fc) was much more potent than monovalent soluble VCAM-1 (sVCAM-1) in supporting 41-specific adhesion (Fig. 1 A), but it still could not rescue the adhesive defect of the 4(Y991A) mutant. These results were confirmed with multiple clones expressing similar levels of 4 and 1 subunits as well as the 1 activation epitope 15/7 (Fig. 1 B and not depicted). Nevertheless, resistance to detachment from different densities of either ICAM-1–Fc or ICAM-1 was comparable between wt- and mutant 41–expressing cells (Fig. 1 C). In agreement with these results, VLA-4–dependent adhesion to TNF-stimulated human umbilical vein endothelial cells (HUVECs) was reduced in Jurkat cells expressing the 4(Y991A) mutant (Fig. 1 D), in particular at shear stresses 5 dyn/cm2, within the upper range of shear stresses prevailing in postcapillary venules where the majority of lymphocyte extravasation takes place (Firrell and Lipowsky, 1989). Whereas most cells expressing the wt 4 firmly arrested on the stimulated HUVEC via their VLA-4, a significant fraction of 4(Y991A) mutant–expressing cells failed to arrest and established endothelial (E)-selectin–dependent rolling on the HUVEC (Fig. 1 D). In the absence of functional E-selectin, the shear resistance of cells expressing the 4(Y991A) mutant was much lower than the shear resistance of cells expressing wt 4 (Fig. 1 D). Because the contribution of LFA-1 to Jurkat arrest was minimal, these data suggest that the Y991A 4 mutant is deficient in establishing 41-mediated shear resistance on endothelial cells expressing VCAM-1 as well as on substrates coated with isolated VCAM-1.
Notably, preformed clustering of wt and mutant 4 subunits on JB4 cells was essentially identical (Fig. 2 A). Real time imaging of JB4 cells that adhered on VCAM-1 also showed identical cell spreading as well as the distribution of both mutant and wt 4 during 1-min cellular contacts before shear application (WT: n = 44, 16% round, 54% polarized with uniform 4, 30% polarized with patched 4; Y911A: n = 27, 18% round, 52% polarized with uniform 4, 30% polarized with patched 4; Fig. 2 B). Notably, the strength of resistance to detachment developed by wt 4 did not correlate with the degree of patching (Fig. 2 B) in contrast to reports on LFA-1–dependent systems (Constantin et al., 2000; Kim et al., 2004). Thus, a mutation of the 4 tail defective in paxillin binding prevents 41-mediated resistance to shear-induced cell detachment independent of cell spreading and 4 patching on VCAM-1.
The 4(Y991A) mutation blocks paxillin association with the 4 tail selectively (Liu et al., 1999). As an alternative test of the role of the 4–paxillin interaction, we exploited a recently identified small molecule inhibitor of this interaction. The compound, designated A7B7C7, blocks the 4–paxillin interaction and interferes with 41-dependent cell migration (Ambroise et al., 2002). This inhibitor, but not a control compound (A6B6C6), attenuated the shear resistance of wt 41–mediated Jurkat cell adhesion to VCAM-1 (Fig. 3 A, left) but had no effect on the residual shear resistance developed by the JB4-4(Y991A) cells (Fig. 3 A, right). Adhesion mediated by the L2–ICAM-1 interaction was also insensitive to the inhibitor (not depicted). Knocking down paxillin expression by up to 75% using transient short inhibitory RNA (siRNA) silencing (Fig. 3 B) resulted in reduced adhesiveness of wt 41–mediated Jurkat cell adhesion to VCAM-1 (Fig. 3 C), with no inhibition of adhesiveness mediated by the 4(Y991A) mutant (Fig. 3 C). Notably, LFA-1–dependent adhesion to ICAM-1 was also insensitive to identical paxillin silencing (not depicted). Thus, both genetic and pharmacological approaches indicate that the 4–paxillin interaction increases the resistance of 41–VCAM-1 contacts to detachment by disruptive shear stresses.
Paxillin association with the 4 subunit promotes 41 anchorage to the cytoskeletonPaxillin binds a number of actin-binding proteins such as talin and vinculin (Brown and Turner, 2004) and does so at sites distinct from the 4-binding site (Liu and Ginsberg, 2000). We next quantified the fraction of detergent-resistant wt 4 or 4(Y991A) retained on NP-40–solubilized cells using fluorescence-tagged integrin-bound 4 mAb (Fig. 4 A). Retention of intact wt and 4(Y991A) was similar and low (20% of the total surface 4; Fig. 4 A). However, the addition of anti–mouse Ig to cluster the mAb-bound wt 4 markedly increased the association of 41 surface integrin with the detergent-insoluble cytoskeleton (Fig. 4 B). In contrast, the same treatment produced a negligible increase in the cytoskeletal association of 4(Y991A)1 (Fig. 4 B). Thus, the 4(Y991A) mutant fails to anchor properly to the actin cytoskeleton in Jurkat T cells.
The 4(Y991A) mutant poorly associates with talin and does not respond to talin suppressionIn light of this poor cytoskeletal anchorage of 4(Y991A)1, we next compared the level of talin associated with the wt or mutant 41 complex in nonadherent Jurkat cells. Notably, constitutive talin binding to the 4(Y991A)1 complex was significantly reduced compared with the wt integrin, as was evident from coprecipitation analysis (Fig. 5 A). Knocking down up to 65% of the total talin content in wt 41–expressing Jurkat cells (Fig. 5 B) retained integrin expression (not depicted) but resulted in significant reduction in their 41-mediated shear resistance on both sVCAM-1 and VCAM-1–Fc (Fig. 5 C, left and right insets, respectively). Notably, identical suppression of talin expression in the 4(Y991A)1-expressing Jurkat cells (Fig. 5 B) had no effect on their low shear resistant adhesion to identical VCAM-1 substrates (Fig. 5 C, right). These results collectively suggest that paxillin association with 41 also recruits talin to the 4–paxillin complex and may enhance talin association with the 1 subunit tail. Thus, both paxillin and talin associations promote 41-dependent cell resistance to detachment from VCAM-1 under shear stress.
4-Paxillin association is not required for 41 avidity for VCAM-1 but increases 4 bond stiffnessAlthough the affinity of integrin 4(Y991A)1 to soluble VCAM-1–Fc is retained (Rose et al., 2003), we considered that Jurkat cells expressing the 4(Y991A)1 mutant might fail to develop shear resistant adhesion as a result of reduced avidity for surface-bound VCAM-1. Comparing wt 41 with 4(Y991A)1 adhesiveness to VCAM-1–coated beads in the absence of applied shear stress, we found that JB4-wt and JB4-4(Y991A) cells bound identically to magnetic beads coated with increasing site densities of VCAM-1–Fc (Fig. 6 A), which is supportive of the normal adhesion of 4(Y991A)1-expressing cells under static conditions. Nevertheless, when VCAM-1–coated beads that bound to JB4-wt cells were exposed to abrupt mechanical stress, these beads were displaced significantly less than beads prebound to JB4-4(Y991A) cells (Fig. 6 B and Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb.200503155/DC1). 4 resistance to displacement required an intact actin cytoskeleton, as JB4-wt cells pretreated with the F-actin–severing drug cytochalasin D exhibited even greater displacement in response to abrupt magnetic stress (Fig. 6 C). These findings, together with the shear-based detachment assays (Fig. 1), collectively suggest that paxillin association with the 41 heterodimer and an intact actin cytoskeleton are both required for ligand-occupied 41 to develop stress-resistant adhesive bonds.
Paxillin association with the 4 tail augments 4-mediated T cell capture on VCAM-1 and MadCAM-1 under shear flowThe 41 and 47 integrins mediate leukocyte capture under physiological shear flow (Alon et al., 1995; Berlin et al., 1995). Therefore, we compared the ability of mutant 4(Y991A) versus wt 4 to support 41-dependent T cell capture by monovalent and bivalent VCAM-1 under continuous shear flow. Consistent with its defective resistance to shear force, 4(Y991A)1 mediated reduced cell capture and arrest on a large range of densities of either monovalent (sVCAM) or bivalent (VCAM-Fc) VCAM-1 (Fig. 7, A and B). This differential behavior was also manifested at different levels of shear stress that were tested (Fig. 7 B, first two panels). Notably, whereas disruption of the actin cytoskeleton by cytochalasin D resulted in marked inhibition of both cell capture and arrest mediated by wt 41, cytochalasin D had no effect on the residual adhesions mediated by the 4(Y991A)1 mutant (Fig. 7 A). Interestingly, the duration of individual 41 tethers, which is a measure of integrin affinity to the ligand (Feigelson et al., 2001), was not altered upon the loss of paxillin binding (Fig. 7 A). Thus, for optimal cell capture under shear flow, the 4 tail of 41 requires associations with the intact actin cytoskeleton.
Jurkat cells express low levels of the 7 integrin subunit; thus, >95% of their 4-integrin subunits are found in 41 heterodimers. Nevertheless, JB4-wt cell capture on high density of the bivalent 47-integrin ligand MadCAM-1–Fc (Berlin et al., 1993) was inhibited by the anti-47 antibody Act-1 (unpublished data). The JB4-4(Y991A) cells formed fivefold fewer tethers on MadCAM-1 than JB4-wt cells, with a diminished fraction of tethers followed by immediate arrests (Fig. 7 B, right). Thus, paxillin association with the 4 subunit enhances the ability of 4 to promote adhesive tethers in the context of both 1 and 7 integrins under continuously applied disruptive shear stress.
Preferential localization of receptors to microvilli increases their availability for interactions with counter ligands under shear flow (von Andrian et al., 1995). Electron microscopic analysis of wt 4 and the 4(Y991A)-tail mutant revealed identical distribution of these variants to microvillar compartments (82 ± 4% for wt 4, n = 222; 80 ± 6% for the 4(Y991A) mutant, n = 196; Fig. 5 C). Furthermore, a higher ratio of the 4(Y991A)-tail mutant localized on microvillar tips than wt 4 (a 4.5 tip/base ratio for the mutant vs. only 1.8 tip/base ratio for wt 4). The number and size of microvillar projections in JB4-wt and JB4-4(Y991A) cells were also comparable (Fig. 7 C). Thus, the enhanced ability of wt 41 to promote adhesive tethers under shear flow was not the result of its preferential distribution to cellular microvilli or to increased localization on microvillar tips.
The 4(Y991A)1 mutant fails to generate productive adhesive bonds with VCAM-1 under disruptive forcesTo examine the effects of disrupting the 4–paxillin interaction at a single molecule level and in the presence of an external force other than shear stress, we next measured the force of unitary adhesive interactions between wt 41 or the 4(Y991A)1 mutant and immobilized VCAM-1 by atomic force microscopy (AFM). JB4-wt or JB4-(Y991A) cells were coupled to the end of an AFM cantilever (Fig. 8 A) and lowered onto a VCAM-1–Fc-coated surface. After a 0.5-s contact, the frequency of productive adhesive events and their strength were analyzed by the degree of deflection experienced by the cantilever during its retraction from the adhesive substrate. Both cell types detached from the VCAM-1 substrate through single jumps, suggesting the breakage of individual bonds during cantilever retraction (Fig. 8 B). The adhesion frequencies of all experiments were maintained below 30%, a level assumed to reflect single 41–VCAM-1 interactions (Zhang et al., 2004). The specificity of the adhesive events detected in this system were confirmed by a similar 70% reduction in total binding events by the blockade of wt 41 with Bio1211 (Lin et al., 1999) or by omission of VCAM-1 from the substrate (Fig. 8 C and not depicted). As indicated by the force histograms derived for JB4-wt or JB4-4(Y991A) cells (Fig. 8 C), the frequency of productive adhesive events developed by 4(Y991A)1 was up to 10-fold lower than those developed by 41 after background subtraction. The distribution of unbinding (rupture) forces measured for the two integrin variants was, however, similar (Fig. 8 C). Thus, paxillin association with the 4 subunit dramatically augments the ability of 41 to form adhesive tethers that resist disruptive forces irrespective to whether these forces are applied during a vertical force loading (AFM) or during cell rotation (shear stress).
Paxillin association with 4 augments shear resistance of integrin tethers independent of ligand-induced conformational changesThe aforementioned data suggest that paxillin binding to 4 is required for mechanical stabilization of cell attachments rather than for cytoplasmic induction of high affinity integrin conformations. Ligand binding to integrins can induce conformational changes in the integrin, resulting in high affinity conformations (Du et al., 1991; Shimaoka et al., 2002). Therefore, we considered the possibility that the reduced tether formation by the 4(Y991A) mutant could reflect defective, instantaneous ligand-induced conformational changes in the integrin under shear stress. We first verified that the 41 ligand Bio1211 provoked similar conformational changes in 41 and 4(Y991A)1 under shear-free conditions, as indicated by the identical induction of the 1 ligand–induced binding site reporter 15/7 epitope by increasing doses of the monovalent 41-specific ligand Bio1211 (Fig. 9 A; Lin et al., 1999). We next tested the intrinsic attachment efficacy of either wt 4 or the 4Y991A mutant to surface-immobilized 4 mAb in the absence of ligand occupancy of the integrin. Notably, the HP1/2 mAb binding to 4 integrins is not sensitive to their affinity to or rearrangement by native ligands (Feigelson et al., 2001) and, thus, should be insensitive to intrinsic or ligand-induced affinity changes under shear stress. Notably, in the presence of shear flow, the 4(Y991A) mutant formed adhesive tethers to immobilized HP1/2 mAb much less efficiently than wt 4 (Fig. 9 B), as was observed for VCAM-1 (Fig. 1). In addition, adhesive contacts generated by the 4(Y991A) mutant after 1 min of static contact also exhibited poor resistance to detachment by increasing shear forces relative to wt 4–mediated contacts (Fig. 9 C). Thus, paxillin association with the 4-integrin tail enhances the ability of the integrin subunit to generate resistance to detachment forces independently of ligand-induced conformational rearrangements under shear stress conditions.
The 4(Y991A)1 mutant responds to inside-out stimulation but develops weaker adhesions to VCAM-1 under shear flowCellular stimulation by various agonists increases integrin adhesiveness in various contexts (Hynes, 2002). We next examined the effects of two prototypic agonists, PMA, a direct agonist of diacyl glycerol–dependent PKCs, and the chemokine SDF-1 (CXCL12) on mutant and wt 4. Exposure of JB4-4(Y991A) cells to soluble PMA or to immobilized SDF-1 resulted in enhanced resistance to detachment from VCAM-1–bearing surfaces (Fig. 10 A), although the overall adhesion strength developed by the 4(Y991A) mutant was lower than that developed by the intact integrin. Further analysis of adhesive tethers formed on VCAM-1 at subsecond contacts also indicated that the ability of initial 4(Y991A)1-dependent Jurkat tethers to convert to immediate firm arrests was enhanced by PMA (Fig. 10 B). Likewise, JB4-4(Y991A) cells efficiently responded to in situ subsecond signals from SDF-1 with a twofold elevated frequency of 41-dependent tethers on VCAM-1 (Fig. 10 B, right). However, overall SDF-1–stimulated tethers mediated by 4(Y991A) cells remained lower than wt 4–mediated tethers. Thus, although the mutant 4 underwent robust activation in response to both chemokine and PMA inside-out signals, its impaired cytoskeletal associations resulted in overall reduced adhesion to VCAM-1 under shear stress.
Discussion
This study shows that the disruption of paxillin binding to the integrin 4 tail abrogates its anchorage to the actin cytoskeleton and impairs the ability of integrin ligand bonds to withstand immediate rupture by shear stress, an AFM-pulling device, or abruptly applied magnetic force. Despite normal distribution on the cell surface and retained avidity to immobilized VCAM-1, in the presence of applied forces, this anchorage-deficient mutant poorly mediates tether formation and rapid adhesion strengthening on its ligand. Paxillin-dependent cytoskeletal anchoring of ligand-occupied 4 integrins may thus underlie their unique capacity to resist disruptive forces and support leukocyte adhesion under shear flow. Thus, although cytoskeletal constraints of integrins were predicted to restrict mobility and clustering on the cell surface and reduce cell adhesiveness (Kucik et al., 1996; Yauch et al., 1997; Kim et al., 2004), we propose that 4 integrins must retain correct cytoskeletal associations to resist immediate rupture by shear stresses exerted at leukocyte contacts with target blood vessels. Our findings indicate that 4-integrin anchorage to the cell cytoskeleton is critical for nascent adhesive contacts to resist immediate rupture by shear stress, but it is not required for integrin binding to the ligand nor for ligand-induced conformational rearrangements in the absence of external force. The anchorage deficiency of the 4-tail mutant resulted in an inability to develop adhesion to a high affinity mAb, which binds the integrin independently of affinity to native ligands (Feigelson et al., 2001; Kinashi et al., 2004). Altogether, these data suggest that paxillin associations with the 4 tail control (a postligand occupancy anchorage step that is critical for tether stabilization under stress), which is a mechanical property underlying the ability of lymphocytes to capture and arrest on endothelial 4-integrin ligands under shear flow. Our experiments on cytokine-activated endothelial cells also predict an increased contribution of this 4–paxillin association to T cells interacting with endothelial beds expressing 4-integrin ligands in the absence of endothelial selectins.
Integrin affinity is controlled by -subunit associations with the talin head domain (Tadokoro et al., 2003) and by Rap1 (Kinashi, 2005) via effectors such as RAPL (regulator of adhesion and cell polarization enriched in lymphoid tissues; Katagiri et al., 2004). The effect of RAPL requires -tail sequences (Katagiri et al., 2004) that are distant from the paxillin-binding site on 4 (Liu and Ginsberg, 2000). The retained affinity of the 4(Y991A) mutant and its capacity to mediate static adhesion suggest that lack of paxillin association with the 4-integrin tail does not interfere with Rap1-dependent signals whether mediated through RAPL or other Rap1 effectors. The reduction in talin association with 4(Y991A)1 did not alter basal 41 affinity for VCAM-1 (Rose et al., 2003), suggesting that the paxillin-mediated association of talin with 41 does not contribute to affinity modulation. On the other hand, the extent of these cytoskeletal associations and an intact actin cytoskeleton critically determine the mechanical strength of 41 VCAM-1 bonds (i.e., tether formation, adhesion strengthening, and resistance to mechanical stress). Thus, we propose that the ability of 4 integrins to translate ligand occupancy into immediate mechanical stability of subsecond adhesive contacts requires paxillin and talin-mediated linkages of 41 to the actin cytoskeleton. The regulation of 41 adhesiveness by talin has never been addressed, especially not under shear stress conditions. The finding that talin suppression impairs the strengthening of wt 41 bonds under strain is reminiscent of results reporting the involvement of talin1 in ligand-driven 51-cytoskeletal bonds in fibroblasts (Jiang et al., 2003). Although different integrins may anchor differently to the cytoskeleton in distinct cell types, this involvement of talin in both 4- and 5-integrin associations with the actin cytoskeleton is consistent with the notion that talin, apart from its role in integrin affinity regulation (Tadokoro et al., 2003), is a key postligand occupancy adaptor that promotes integrin bond stabilization in distinct mechanical contexts and cellular environments.
Our results highlight the role of the -integrin subunit rather than the subunit in postligand binding adhesion strengthening of the 41–VCAM-1 bond under mechanical strain. Previous findings suggested that a nearly complete truncation of the 4-cytoplasmic tail impairs 41 adhesion strengthening without altering initial cell capture to VCAM-1 under shear flow (Alon et al., 1995; Kassner et al., 1995). This truncation of the 4-integrin tail also reduced integrin mobility (Yauch et al., 1997) and may have increased integrin cytoskeletal anchorage via the intact 1 subunit, although this was not experimentally demonstrated. Therefore, in these earlier studies, it was impossible to distinguish between the contributions of 4 anchorage versus mobility to rapid mechanical stabilization of 4 integrin–mediated tethers. Our present results provide the first direct evidence for a positive role of 4 anchorage for the earliest stabilization events of 41–VCAM-1 bonds subjected to mechanical strain.
In addition to the 4 Y991 residue, the phosphorylation level of the 4 serine 988 has been shown to control the degree of 4 association with paxillin (Han et al., 2001). A dephosphorylated serine variant mimicked by the phosphodeficient mutant 4 S988A was reported to bind paxillin at enhanced levels (Nishiya et al., 2005). Interestingly, this phosphodeficient mutant did not properly anchor to the cytoskeleton and supported reduced adhesiveness to VCAM-1 (unpublished data). These findings, together with the paxillin-silencing data of this study, suggest that paxillin binding to the 4 subunit is required but is insufficient to anchor 4 to the cytoskeleton. Thus, 4 phosphorylation, which is postulated to attenuate paxillin binding to the 4 subunit, is in fact required, at least at a basal level, for proper cytoskeletal 4 association and productive adhesiveness under shear stress. Overphosphorylation of 4, which reduces paxillin association, may, on the other hand, attenuate both anchorage and adhesiveness. Studies are ongoing to address both the positive and negative effects of serine phosphorylation on 4 anchorage and function under strain.
4 association with paxillin enhances the activation of the focal adhesion kinases FAK and PYK-2 after 41 ligation (Liu et al., 1999; Rose et al., 2003). This association also restricts Rac activation at the leading edge via recruitment of the Arf GTPase-activating protein (Nishiya et al., 2005). Nevertheless, at 1-min contacts with VCAM-1, cells expressing the 4-tail mutant spread normally on VCAM-1. Suppression of tyrosine phosphorylation or inhibition of PYK-2 activity in Jurkat T cells had no effect on 41-mediated adhesion strengthening developed under shear stress (unpublished data). Thus, the ability of paxillin association with 41 to enhance integrin anchorage to the cytoskeleton and promote mechanical stability of adhesive tethers at short-lived contacts is distinct from its roles in focal adhesion turnover and Rac deactivation during cell spreading on VCAM-1–containing substrates (Nishiya et al., 2005). Altogether, our findings suggest that modulating mechanical properties of 4 integrins by the inhibition of specific associations between 4-cytoplasmic tails and the cytoskeleton may be a selective strategy to fine tune integrin-mediated adhesion under shear stress without altering integrin affinity.
Materials and methods
Reagents and antibodiesRecombinant seven-domain human VCAM-1 (sVCAM-1) was provided by B. Pepinsky (Biogen, Cambridge, MA). VCAM-1–Fc fusion protein containing seven-domain VCAM-1 fused to IgG was generated as described previously (Rose et al., 2000). VCAM-1–Fc constructed from domains 1 and 2 of VCAM-1 fused to Fc, termed 2D VCAM-1–Fc, was provided by B. Pepinsky. Affinity-purified human full-length spleen-derived ICAM-1 was a gift from T. Springer (Harvard University, Boston, MA). ICAM-Fc and SDF-1 were purchased from R&D Systems. BSA (fraction V), poly-L-lysine, and Ca2+/Mg2+-free HBSS were obtained from Sigma-Aldrich. Human serum albumin (fraction V) and PMA were purchased from Calbiochem. The 4-integrin function–blocking HP1/2 mAb, the E-selectin–blocking mAb BB11, the 1-specific TS2/16 mAb, the 4-specific nonblocking 5BG10 mAb (all provided by B. Pepinsky), the 1-integrin subunit mAb 15/7 (provided by T. Yednock, Elan Pharmaceuticals, San Francisco, CA; Yednock et al., 1995), and the anti-47 Act-1 (a gift from M.J. Briskin, Millennium Pharmaceuticals, Cambridge, MA) were all used as purified Ig. Antitalin mAb (clone 8d4) was purchased from Sigma-Aldrich. Antipaxillin mAb (clone 349) was purchased from BD Transduction Laboratories. Goat polyclonal anti-4 Ab (clone C-20) was purchased from Santa Cruz Biotechnology, Inc.
Cell culture and flow cytometryJurkat cells deficient in 4 (JB4) were stably transfected with either wt 4 or 4(Y991A) cDNA as described previously (Liu et al., 1999). Cells were subcloned, and multiple clones expressing identical levels of 4 and 1 subunits were taken for functional analysis. Clones were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 mM nonessential amino acids, and antibiotics (Biological Industries). Primary HUVECs were established as previously described (Shamri et al., 2005). HUVECs were left intact or stimulated for 4 h with 0.1 ng/ml TNF- (R&D Systems) before experiments. Staining and FACS analysis were performed as previously described (Feigelson et al., 2003).
Immunofluorescence staining and immunoelectron microscopyFor 4-integrin immunostaining, Jurkat cells were washed in PBS and incubated with 10 μg/ml anti-4 B5G10 mAb for 30 min at 4°C. Cells were washed once with PBS + 5 mM EDTA and twice with PBS/0.1% BSA, and 4 integrins were stained with AlexaFluor546-conjugated anti–mouse Ab (Invitrogen) and fixed in 3% PFA in PBS (30 min at RT). Control cells were fixed before mAb incubation steps. Cells were attached to poly-L-lysine–coated glass slides, and coverslips were mounted with elvanol overnight and analyzed with a confocal microscope (TE300; Nikon) and a laser-scanning system (model 2000; Bio-Rad Laboratories).
4 localization was assessed by immunoelectron microscopy as previously described (Chen et al., 1999). In brief, cultured Jurkat cells were washed and prefixed in 0.1 M phosphate buffer, pH 7.4, containing 2% PFA and 0.05% glutaraldehyde. Washed cells in H/H medium (HBSS containing 2 mg/ml BSA and 10 mM Hepes, pH 7.4, supplemented with 1 mM CaCl2 and 1 mM MgCl2) were incubated with 10 μg/ml anti-4 B5G10 mAb for 40 min at 22°C. Washed cells were stained with 10 μg/ml rabbit anti–mouse Ig, washed, and incubated for 45 min with 5 nm gold particle–conjugated goat anti–rabbit (Aurion). Ultrathin sections (70–90 nm) of 40–60 cells for each experimental group were examined with an electron microscope (Tecnai 12; FEI) under 120 kV, and images were taken using a CCD camera (Megaview 3; Soft Imaging System). In each experimental group analyzed, the number of 4-specific gold particles on microvillar projections was compared with that on adjacent cell body compartments of identical dimensions.
siRNA-mediated silencing of paxillin and talinSilencing of talin expression in Jurkat cells was achieved by a talin1-specific 21-nucleotide siRNA (Dharmacon) corresponding to positions 6,043–6,063 relative to the talin1 mRNA start codon (Shamri et al., 2005). Silencing of paxillin was conducted as described previously (Nishiya et al., 2005). Control transfections were performed with a fluorescein-labeled 21-nucleotide duplex directed to Luciferase GL2. Transfection of T cells was performed by electroporation using the Nucleofection system (Amaxa). Transfected cells were maintained in culture medium. Talin and paxillin expression monitored by immunoblotting was maximally suppressed 72 h posttransfection, and time points were chosen for subsequent functional assays. Immunoprecipitation of 4 was performed as previously described (Feigelson et al., 2003).
Quantification of integrin anchorage to the cytoskeletonCells were stained with 10 μg/ml of the FITC-conjugated anti-4 mAb HP1/2 at 4°C for 30 min, washed twice with H/H medium supplemented with 1 mM CaCl2 and 1 mM MgCl2, and left either untreated or cross-linked with secondary antibodies at 4°C for 30 min followed by two washes as described previously (Geppert and Lipsky, 1991; Evans et al., 1999). All cells were then incubated at RT for 30 min with the cytoskeletal stabilizing buffer (CSB; 50 mM NaCl, 2 mM MgCl2, 0.22 mM EGTA, 13 mM Tris, pH 8.0, 1 mM PMSF, 10 mM iodacetamide, and 2% FCS) alone or supplemented with 0.1% NP-40. The intact cells or their recovered detergent-insoluble cytoskeletal fractions were washed in detergent-free CSB, fixed in 1% PFA/PBS, and analyzed by flow cytometry. Under these conditions, the majority of detergent-treated cells retain their shape and size. The ratio of mean fluorescence intensity recovered in detergent-treated cells divided by that of cells not exposed to the detergent yields the fraction of mAb-bound 4 integrin that is resistant to detergent extraction; i.e., anchored to the (detergent resistant) cytoskeletal fraction of the cell.
VCAM-1 microbead–binding assays and integrin bond stiffnessProtein A–coated magnetic M-280 Dynabeads (Dynal) were coated at RT with various concentrations (0.004–1 μg/ml) of 2D VCAM-Fc in H/H binding medium, washed according to the manufacturer's instructions, and stored on ice. Cells and VCAM-1–coated beads were mixed at RT for 1 min in binding medium at a concentration of 107 cells/ml at a cell/bead ratio of 1:8 followed by a threefold dilution in binding medium. The cellular side scatter, distinguishing between bead-bound and bead-free cells, was analyzed immediately in a FACScan flow cytometer (Becton Dickinson). Background binding determined with protein A–coated beads was <10% of the maximal binding observed at VCAM-1 saturation and was subtracted from the total binding results.
The mechanical stiffness of 41/VCAM-1 adhesions was measured by electromagnetic pulling cytometry using VCAM-1–coated beads (Matthews et al., 2004). The detailed method is described in supplemental material (available at http://www.jcb.org/cgi/content/full/jcb.200503155/DC1).
AFM measurementsAll force measurements were conducted at 35 ± 2°C using a previously described AFM apparatus (Benoit et al., 2000). In brief, a microfabricated Si3N4 cantilever tip (Park Scientific Instruments) was coated with 0.1 mg/ml of the anti-CD43 mAb (R&D Systems). The spring constants of the cantilevers used were determined at 4.7 ± 0.6 mN/m. A single cell was immobilized on the cantilever tip shortly before experimentation. The device was mounted with a piezo-actuator (Piezosystem Jena) on an inverted optical microscope (Carl Zeiss MicroImaging, Inc.) containing a heating stage. A diode laser beam focused on the sensor was used to measure the displacement of the cantilever by the laser beam deflection on a two-segment photodetector. The cell adhering to the cantilever was positioned above an adhesive substrate coated with 2D VCAM-1–Fc captured via human IgG Fc mAb (Jackson ImmunoResearch Laboratories). The cantilever was lowered until the sensor detected a contact force equal to a preselected value (typically 50 pN). After the contact was established for a dwelling time of 500 ms, the cell-bearing cantilever was lifted up by the piezo-actuator, and the de-adhesion force was monitored by a force–distance plot (Fig. 5 B). From this plot, the last detectable de-adhesion force was calculated. For each cell, 50–200 force–distance plots were collected within 30 min. All de-adhesion events collected in at least 10 independent experiments were presented in histograms (Fig. 5 C).
Laminar flow adhesion assaysPurified ligands or mAbs were coated on polystyrene plates as previously described (Grabovsky et al., 2000). Site densities of coated sVCAM-1 and VCAM-1–Fc were determined as previously described (Grabovsky et al., 2000; Sigal et al., 2000). The polystyrene plates were each assembled on the lower wall of the flow chamber (260-um gap) as previously described (Dwir et al., 2000; Feigelson et al., 2001). Cells were washed with cation-free H/H medium, resuspended in binding medium (H/H medium supplemented with 1 mM CaCl2 and 1 mM MgCl2), and perfused through the flow chamber at the desired shear stress. To disrupt actin cytoskeleton, cells were pretreated for 15 min with 20 μM cytochalasin D (Calbiochem) or carrier solution (0.1% DMSO). All flow experiments were conducted at 37°C. Tethers were defined as transient if cells attached briefly (<2 s) to the substrate and as arrests if they immediately arrested and remained stationary for at least 5 s of continuous flow. Frequencies of adhesive categories within differently pretreated cells or rates of cell accumulation on adhesive substrates were determined as a percentage of cells flowing immediately over the substrates, as previously described (Grabovsky et al., 2000). To assess rapid development of integrin avidity to the ligand at 1-min stationary contacts, cells were allowed to settle onto the substrate for 1 min at stasis. Flow was then initiated and increased step-wise every 5 s by a programmed set of rates. At the indicated shear stresses, the number of cells that remained bound was expressed relative to the number of cells originally settled on the substrate. Over 95% of tethers to VCAM-1 were blocked by pretreating cells with 10 μg/ml of the 4-blocking mAb HP1/2. Live imaging of 4 on Jurkat cells prelabeled with AlexaFluor488-conjugated B5G10 mAb that settled on VCAM-1 was conducted with Delta Vision Spectris RT (Applied Precision). 4 patching was quantified using Image J software (National Institutes of Health).
Online supplemental materialFig. S1 shows the analysis of VCAM-1–coated bead displacement during a magnetic force pulse applied on wt Jurkat cells. The supplemental Materials and methods section describes the experimental setup.
Acknowledgments
We thank S. Schwarzbaum for editorial assistance.
R. Alon is the Incumbent of The Tauro Career Development Chair in Biomedical Research. This research was supported by the Fogarty International Research Collaboration Awards and was partially supported by the Israel Science Foundation and MAIN, the EU6 Program for Migration and Inflammation. This work was also supported by National Institutes of Health (NIH) grants AR27214 and HL57009 to M.H. Ginsberg, NIH grant CA45548 to D.E. Ingber, and NIH grant P30AR47360 to D.M. Rose. The work of D.M. Rose was additionally supported by the Department of Veterans Affairs Merit Review Entry Program Award and by the Arthritis Foundation.
References
Alon, R., and S. Feigelson. 2002. From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin. Immunol. 14:93–104.
Alon, R., P.D. Kassner, M.W. Carr, E.B. Finger, M.E. Hemler, and T.A. Springer. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243–1253.
Ambroise, Y., B. Yaspan, M.H. Ginsberg, and D.L. Boger. 2002. Inhibitors of cell migration that inhibit intracellular paxillin/alpha4 binding: a well-documented use of positional scanning libraries. Chem. Biol. 9:1219–1226.
Benoit, M., D. Gabriel, G. Gerisch, and H.E. Gaub. 2000. Discrete interactions in cell adhesion measured by single-molecule force spectroscopy. Nat. Cell Biol. 2:313–317.
Berlin, C., E.L. Berg, M.J. Briskin, D.P. Andrew, P.J. Kilshaw, B. Holzmann, I.L. Weissman, A. Hamann, and E.C. Butcher. 1993. 47 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 74:185–195.
Berlin, C., R.F. Bargatze, J.J. Campbell, U.H. von Andrian, M.C. Szabo, S.R. Hasslen, R.D. Nelson, E.L. Berg, S.L. Erlandsen, and E.C. Butcher. 1995. 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80:413–422.
Brown, M.C., and C.E. Turner. 2004. Paxillin: adapting to change. Physiol. Rev. 84:1315–1339.
Carman, C.V., and T.A. Springer. 2003. Integrin avidity regulation: are changes in affinity and conformation underemphasized Curr. Opin. Cell Biol. 15:547–556.
Chen, C., J.L. Mobley, O. Dwir, F. Shimron, V. Grabovsky, R.L. Lobb, Y. Shimizu, and R. Alon. 1999. High affinity VLA-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow. J. Immunol. 162:1084–1095.
Constantin, G., M. Majeed, C. Giagulli, L. Piccio, J.Y. Kim, E.C. Butcher, and C. Laudanna. 2000. Chemokines trigger immediate 2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity. 13:759–769.
Du, X.P., E.F. Plow, A.L. Frelinger 3rd, T.E. O'Toole, J.C. Loftus, and M.H. Ginsberg. 1991. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell. 65:409–416.
Dwir, O., G.S. Kansas, and R. Alon. 2000. An activated L-selectin mutant with conserved equilibrium binding properties but enhanced ligand recognition under shear flow. J. Biol. Chem. 275:18682–18691.
Dwir, O., G.S. Kansas, and R. Alon. 2001. The cytoplasmic tail of L-selectin regulates leukocyte capture and rolling by controlling the mechanical stability of selectin:ligand tethers. J. Cell Biol. 155:145–156.
Evans, S.S., D.M. Schleider, L.A. Bowman, M.L. Francis, G.S. Kansas, and J.D. Black. 1999. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J. Immunol. 162:3615–3624.
Feigelson, S.W., V. Grabovsky, E. Winter, L.L. Chen, R.B. Pepinsky, T. Yednock, D. Yablonski, R. Lobb, and R. Alon. 2001. The src kinase p56Lck upregulates VLA-4 integrin affinity: implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin. J. Biol. Chem. 276:13891–13901.
Feigelson, S.W., V. Grabovsky, R. Shamri, S. Levy, and R. Alon. 2003. The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to VCAM-1 under shear flow. J. Biol. Chem. 278:51203–51212.
Firrell, J.C., and H.H. Lipowsky. 1989. Leukocyte margination and deformation in mesenteric venules of rat. Am. J. Physiol. 256:H1667–H1674.
Geppert, T.D., and P.E. Lipsky. 1991. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J. Immunol. 146:3298–3305.
Grabovsky, V., S. Feigelson, C. Chen, R. Bleijs, A. Peled, G. Cinamon, F. Baleux, F. Arenzana-Seisdedos, T. Lapidot, Y. van Kooyk, et al. 2000. Subsecond induction of 4 integrin clustering by immobilized chemokines enhances leukocyte capture and rolling under flow prior to firm adhesion to endothelium. J. Exp. Med. 192:495–505.
Han, J., S. Liu, D.M. Rose, D.D. Schlaepfer, H. McDonald, and M.H. Ginsberg. 2001. Phosphorylation of the integrin alpha 4 cytoplasmic domain regulates paxillin binding. J. Biol. Chem. 276:40903–40909.
Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673–687.
Jiang, G., G. Giannone, D.R. Critchley, E. Fukumoto, and M.P. Sheetz. 2003. Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin. Nature. 424:334–337.
Kansas, G.S., K. Ley, J.M. Munro, and T.F. Tedder. 1993. Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin. J. Exp. Med. 177:833–838.
Kassner, P.D., R. Alon, T.A. Springer, and M.E. Hemler. 1995. Specialized functional properties of the integrin 4 cytoplasmic domain. Mol. Biol. Cell. 6:661–674.
Katagiri, K., N. Ohnishi, K. Kabashima, T. Iyoda, N. Takeda, Y. Shinkai, K. Inaba, and T. Kinashi. 2004. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat. Immunol. 5:1045–1051.
Kim, M., C.V. Carman, W. Yang, A. Salas, and T.A. Springer. 2004. The primacy of affinity over clustering in regulation of adhesiveness of the integrin L2. J. Cell Biol. 167:1241–1253.
Kinashi, T. 2005. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol. 5:546–559.
Kinashi, T., M. Aker, M. Sokolovsky-Eisenberg, V. Grabovsky, C. Tanaka, R. Shamri, S. Feigelson, A. Etzioni, and R. Alon. 2004. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood. 103:1033–1036.
Kucik, D.F., M.L. Dustin, J.M. Miller, and E.J. Brown. 1996. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J. Clin. Invest. 97:2139–2144.
Lin, K., H.S. Ateeq, S.H. Hsiung, L.T. Chong, C.N. Zimmerman, A. Castro, W.C. Lee, C.E. Hammond, S. Kalkunte, L.L. Chen, et al. 1999. Selective, tight-binding inhibitors of integrin 41 that inhibit allergic airway responses. J. Med. Chem. 42:920–934.
Liu, S., and M.H. Ginsberg. 2000. Paxillin binding to a conserved sequence motif in the 4 integrin cytoplasmic domain. J. Biol. Chem. 275:22736–22742.
Liu, S., S.M. Thomas, D.G. Woodside, D.M. Rose, W.B. Kiosses, M. Pfaff, and M.H. Ginsberg. 1999. Binding of paxillin to 4 integrins modifies integrin-dependent biological responses. Nature. 402:676–681.
Matthews, B.D., D.R. Overby, F.J. Alenghat, J. Karavitis, Y. Numaguchi, P.G. Allen, and D.E. Ingber. 2004. Mechanical properties of individual focal adhesions probed with a magnetic microneedle. Biochem. Biophys. Res. Commun. 313:758–764.
Nishiya, N., W.B. Kiosses, J. Han, and M.H. Ginsberg. 2005. An 4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat. Cell Biol. 7:343–352.
Rose, D.M., P.M. Cardarelli, R.R. Cobb, and M.H. Ginsberg. 2000. Soluble VCAM-1 binding to 4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells. Blood. 95:602–609.
Rose, D.M., S. Liu, D.G. Woodside, J. Han, D.D. Schlaepfer, and M.H. Ginsberg. 2003. Paxillin binding to the 4 integrin subunit stimulates LFA-1 (integrin L2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2. J. Immunol. 170:5912–5918.
Shamri, R., V. Grabovsky, J.M. Gauguet, S. Feigelson, E. Manevich, W. Kolanus, M.K. Robinson, D.E. Staunton, U.H. von Andrian, and R. Alon. 2005. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat. Immunol. 6:497–506.
Shimaoka, M., J. Takagi, and T.A. Springer. 2002. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31:485–516.
Sigal, A., D.A. Bleijs, V. Grabovsky, S.J. van Vliet, O. Dwir, C.G. Figdor, Y. van Kooyk, and R. Alon. 2000. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J. Immunol. 165:442–452.
Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301–314.
Tadokoro, S., S.J. Shattil, K. Eto, V. Tai, R.C. Liddington, J.M. de Pereda, M.H. Ginsberg, and D.A. Calderwood. 2003. Talin binding to integrin beta tails: a final common step in integrin activation. Science. 302:103–106.
van Kooyk, Y., and C.G. Figdor. 2000. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr. Opin. Cell Biol. 12:542–547.
von Andrian, U.H., S.R. Hasslen, R.D. Nelson, S.L. Erlandsen, and E.C. Butcher. 1995. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell. 82:989–999.
Yauch, R.L., D.P. Felsenfeld, S.K. Kraeft, L.B. Chen, M.P. Sheetz, and M.E. Hemler. 1997. Mutational evidence for control of cell adhesion through integrin recruitment, independent of ligand binding. J. Exp. Med. 186:1347–1355.
Yednock, T.A., C. Cannon, C. Vandevert, E.G. Goldbach, G. Shaw, D.K. Ellis, C. Liaw, L.C. Fritz, and L.I. Tanner. 1995. 41 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J. Biol. Chem. 270:28740–28750.
Zhang, X., S.E. Craig, H. Kirby, M.J. Humphries, and V.T. Moy. 2004. Molecular basis for the dynamic strength of the integrin 41/VCAM-1 interaction. Biophys. J. 87:3470–3478.(Ronen Alon, Sara W. Feige)